It's time to ask about VELSIPITY—one pill, once a day.
A treatment option for moderate to severe UC with safety data* and proven efficacy†
*VELSIPITY safety was studied across 3 different clinical trials and efficacy was studied in 2 trials in people with moderate to severe ulcerative colitis who had trouble tolerating, were not fully responding, or had a loss of response to previous treatments such as steroids, 5-ASAs‡ like mesalamine, biologics, or JAK inhibitors.
†Some saw remission by Week 12 and Week 52.
‡5-ASAs are 5-aminosalicylic acid derivatives.
JAK= Janus kinase.
More people on VELSIPITY achieved clinical remission* in just 3 months versus those taking the placebo.
VELSIPITY works in a different way than most UC therapies.
How VELSIPITY works is not fully known.
The safety of VELSIPITY was studied in a clinical program with 577 participants taking VELSIPITY across 3 placebo-controlled studies.
Explore the details of VELSIPITY.
Click on a subject to learn more.
Not a steroid. Not a biologic. VELSIPITY is an option for moderate to severe UC that's in the middle.
Want to learn more about VELSIPITY?